This was substantiated by a 1.3-fold increase in the population of HPV16-specific (tetramer+) CD8+ T cells and a substantial 7.0-fold elevation in IFN-γ-secreting CD8+ T cells upon tumor cell stimulation, compared to the group receiving only the protein treatment (Fig. 3d‒f). The gene discussed is CD8A; the disease is neoplasm.